Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > General > Intense pulsed light therapy shows long-term benefits for dry eye after SMILE surgery
  • General

Intense pulsed light therapy shows long-term benefits for dry eye after SMILE surgery

Ophthalmology 360

Intense pulsed light (IPL) therapy is more effective and safer than conventional medication for treating dry eye syndrome after SMILE surgery, with sustained long-term benefits, while diabetes remains a key factor that can worsen outcomes and increase adverse events, according to a study.

Researchers compared IPL treatment with conventional medication in post-SMILE patients, analyzing outcomes over 6 months. The study found that IPL significantly improved key measures of eye health, including ocular surface disease index scores, tear breakup time, Schirmer test results, eye dryness scores, and meibomian gland function. Intense pulsed light also reduced the risk of adverse events compared with conventional therapy.

Diabetes emerged as a major factor influencing treatment outcomes, increasing both dry eye severity and the likelihood of complications. However, IPL therapy’s benefits were sustained over time, showing superior long-term efficacy and safety.

Reference

Lai M, Zhong J, Lu Z, et al. Clinical study on the safety and efficacy of intense pulsed light in the treatment of dry eyes after full femtosecond small incision lenticule extraction. Medicine (Baltimore). 2025;104(37):e44161. doi: 10.1097/MD.0000000000044161. PMID: 40958233; PMCID: PMC12440531.

Share

Related Content

  • General

Glaucoma may signal complications in intraocular cancers, review suggests

  • General

XEN63 Gel Stent shows sustained glaucoma control over 3 years

  • General

Triple-layer decellularized amniotic membrane linked to low recurrence and minimal complications

  • General

Best of 2025: Imaging advances and therapeutic progress across ophthalmology

  • Cataract

It has never been a better time to be a cataract surgeon: trends and advancements in cataract and refractive surgery

34 Mins Watch
  • General

Glaucoma Insights of 2024: Breakthroughs in Testing, Treatment, and Surgery

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon